GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bayer BAYN.DE · EUR

Health Care · Pharmaceuticals · XETRA · 🇩🇪 Germany

DAXEuro Stoxx 50

Compare

56.62

+1.87%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Bayer — daily XETR:BAYN End of day
Market value
€55.62bn
Last close × shares
Volume
2.6m
Shares, 9 Nov 2026
Dividend yield
0.20%

About Bayer

Its shares trade on XETRA under the ticker BAYN.DE. It has been listed since 28 November 1997. It is a member of the DAX and Euro Stoxx 50. In the fiscal year to 31 December 2025, it reported revenue of €45.58bn and a net loss of €3.62bn. At that date it held total assets of €110.61bn and shareholders' equity of €25.95bn.

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. The company is headquartered in Leverkusen, Nordrhein-Westfalen. The firm's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

Figures and description from our data supplier, not checked against the company's own report.

More about Bayer →

Latest on Bayer

Our reporting

Next results

24 Feb 2027

Due on 24 Feb 2027. Analysts expect earnings of 0.52 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Bayer's ticker?

Bayer trades as BAYN.DE on XETRA, under ISIN DE000BAY0017.

What was Bayer's last closing price?

56.62 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Bayer next report results?

Results are expected on 24 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.